In 2010, McKinsey & Company suggested that public private partnerships could be instrumental in creating a fund for health insurance for low-income families. Some of the salient feature of such partnership would be:

 o Annual contribution  to fund by the government and pharmaceutical companies (3% of revenue)
 o Government should provide technical expertise in fundraising and allocation
 o Pharmaceutical companies should identify drug classes/ therapeutic areas that need funding/insurance
 o Benazir Income Support Programme (BISP) can be used to target Below Poverty Line families to provide them access to free or discounted medicines

Public and private sector collaboration improves service, effectiveness and efficiency and helps reduce cost. Pakistan has around 45 million Below Poverty Line citizens that do not have access to medicines due to low availability in public pharmacies.

A Central Drug Bank could be formed with a centralized, transparent procurement model and fair delivery process that would improve access to therapy for the non-affording. If the pharmaceutical industry is given equitable commercial conditions for the majority of portfolio products to compete in a free market, it could be viable for industry to supply select products to the Central Drug Bank at subsidized rates.